Suivre
Colin Baigent
Colin Baigent
Professor of Epidemiology, Oxford University
Adresse e-mail validée de ctsu.ox.ac.uk - Page d'accueil
Titre
Citée par
Citée par
Année
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
168592017
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antithrombotic Trialists' Collaboration
Bmj 324 (7329), 71-86, 2002
13363*2002
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The …
G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ...
European heart journal 42 (5), 373-498, 2021
84312021
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials
C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, ...
The Lancet 376 (9753), 1670-1681, 2010
8113*2010
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
79622020
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...
Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015
79102015
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
ES Unit
Lancet 366 (9493), 1267-1278, 2005
77452005
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other …
European journal of preventive cardiology 19 (4), 585-667, 2012
71512012
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the …
J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...
European heart journal 41 (3), 407-477, 2020
66362020
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
Prospective Studies Collaboration
The Lancet 373 (9669), 1083-1096, 2009
60142009
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute …
JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ...
European heart journal 42 (14), 1289-1367, 2021
49742021
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the …
SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, ...
European heart journal 41 (4), 543-603, 2020
42892020
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and …
F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...
European heart journal 41 (2), 255-323, 2020
42712020
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
C Baigent, L Blackwell, R Collins, J Emberson, J Godwin, R Peto, J Buring, ...
Lancet 373 (9678), 1849-1860, 2009
36232009
2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of …
A Vahanian, F Beyersdorf, F Praz, M Milojevic, S Baldus, J Bauersachs, ...
European heart journal 43 (7), 561-632, 2022
36212022
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
F Turnbull, B Neal, C Algert, J Chalmers, M Woodward, S MacMahon, ...
Lancet 362 (9395), 1527-1535, 2003
31072003
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo …
C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ...
The Lancet 377 (9784), 2181-2192, 2011
29172011
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient …
J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ...
The Lancet 384 (9958), 1929-1935, 2014
26002014
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ...
Lancet (London, England) 380 (9841), 581-590, 2012
22572012
Cholesterol Treatment Trialists'(CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 …
C Baigent
Lancet 366, 1267-1278, 2005
20972005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20